Research and Markets: Global and Chinese Dietary Supplement Industry Report, 2011-2012: China Approves 11,413 Types of Domestic Dietary Supplement By March 2012
Research and Markets (http://www.researchandmarkets.com/research/jtqxlh/global_and) has announced the addition of the "Global and Chinese Dietary Supplement Industry Report, 2011-2012" report to their offering.
In recent years, the dietary supplement industry has entered a new golden development stage in China, with the market size hitting RMB105 billion in 2011 and presenting a CAGR of 11.4% or so during 2006-2011.
Since the Ministry of Health of the People's Republic of China enforced the Examination and Approval System in 1996, according to the data of the State Food and Drug Administration (SFDA), China had approved 11,413 types of domestic dietary supplement and 656 types of imported dietary supplement by March 2012. In 2011, China examined and approved the registration of 813 types of dietary supplement (up 14.5% from 2010), including 800 types of domestic dietary supplement and 13 types of imported dietary supplement.
Shandong Dong-E E-Jiao Group is China's largest donkey-hide gelatin enterprise. In 2011, the company's proceeds from donkey-hide gelatin products achieved RMB2.289 billion, contributing to 84.67% of company's revenue, with the product gross margin of 70.83%. The company mainly sells products in East China. Specifically, its revenue from East China accounted for 37.2%, that from South China 21.1%, and that from North China and Southwest China 8.2% each.
By-Health is a leader in Chinese nutritional dietary supplement market, boasting more than 330 dealers across the country. In 2011, the number of sales terminals in China registered 21,000 or more, up 8,000-plus against that at the end of 2010. From 2007 to 2011, the company's operating revenue showed a CAGR of 77.1%.
- Joincare Pharmaceutical Group Industry Co., Ltd
- Shandong Dong-E E-Jiao Group
- Hainan Yedao (Group) Co., Ltd
- Neptunus Bioengineering Co., Ltd
- North China Pharmaceutical Group Corp (NCPC)
- Hailisheng Group
- Lei Shi
- Hong Fu Loi Holdings Limited
- Shanghai Jiaoda ONLLY Co., Ltd
- Harbin Pharmaceutical Group Co., Ltd
- Amway (China) Co., Ltd
- Ruinian International Limited
- Jiangzhong Medical Co., Ltd (JZJT)
- Sanjing Pharmaceutical Co., Ltd
- Perfect (China) Co., Ltd
- Shanghai Goldpartner Biotech Co., Ltd
- Jiangsu Sihuan Bioengineering Co., Ltd
- Zhen-Ao Group
- Tiens Group Co., Ltd
For more information visit http://www.researchandmarkets.com/research/jtqxlh/global_and